Breast Cancer Trial, Recruiting (NCT06094257)

Breast Cancer Trial, Recruiting NCT06094257 Sponsor: Weill Medical College of Cornell University Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06094257 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who are scheduled to have a gender mastectomy (breast removal surgery), including nipple-sparing mastectomy, mastectomy with nipple graft, or mastectomy with breast implant or tissue reconstruction
People who are willing and able to give informed consent to participate

Who may not be able to join:

People who have a nerve condition that would prevent sensation from being tested or measured
People who the trial investigator considers unsuitable for the study or unlikely to attend follow-up appointments
People who are currently taking medication known to affect nerve regrowth or cause nerve damage in the hands, feet, or limbs
People having reconstruction on both sides where one reconstructed breast would receive nerve repair and the other would not (non-matching treatments on each side)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa Gfrerer, MD, PhD, Weill Medical College of Cornell University

Phone: 646.962.4250

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06094257

Sponsor: Weill Medical College of Cornell University

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 646.962.4250

More information: https://clinicaltrials.gov/study/NCT06094257

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who are scheduled to have a gender mastectomy (breast removal surgery), including nipple-sparing mastectomy, mastectomy with nipple graft, or mastectomy with breast implant or tissue reconstruction
People who are willing and able to give informed consent to participate

Who may not be able to join:

People who have a nerve condition that would prevent sensation from being tested or measured
People who the trial investigator considers unsuitable for the study or unlikely to attend follow-up appointments
People who are currently taking medication known to affect nerve regrowth or cause nerve damage in the hands, feet, or limbs
People having reconstruction on both sides where one reconstructed breast would receive nerve repair and the other would not (non-matching treatments on each side)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weill Medical College of Cornell University

Registry

ClinicalTrials.gov

Start date

9 February 2022

Est. completion

1 March 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Breast Q scores; Change in Gender-Q scores; Change in cold detection threshold; Change in warm detection threshold; Change in heat pain threshold; Change in mechanical detection threshold; Change in two-point discrimination; Change in mechanical pain threshold; Change in pressure pain threshold; Change in Tinel sensation; Change in vibration sensation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov